EAN 2025 Archives - Medical Conferences

Home > Neurology > EAN 2025

European Academy of Neurology
21–24 June 2025
Helsinki, Finland

Lecanemab in AD: not a paradigm shift, but a small step forward

Presented By

Dr Matilde Bruno, University of Rome Tor Vergata, Italy

Conference

EAN 2025

Type

News article

25 June 2025 10:49

Why a good result of migraine treatment may not be good enough

Presented By

Dr Edoardo Caronna, Vall d’Hebron University Hospital, Spain

Conference

EAN 2025

Type

News article

24 June 2025 12:27

Online First

Similar efficacy of anti-CGRP mAbs in short- and long-term migraine prevention

Presented By

Dr Edoardo Caronna , Vall d’Hebron Hospital, Barcelona, Spain

Conference

EAN 2025

Type

News article

26 June 2025 13:19

Occipital nerve stimulation is no more effective than placebo in cluster headache

Presented By

Dr. Ida Stisen Fogh-Andersen, Aarhus University Hospital, Denmark

Conference

EAN 2025

Type

News article

26 June 2025 13:16

Rituximab does not halt progression in non-active secondary progressive MS

Presented By

Nadine Ehrhardt , University of Augsburg, Germany

Conference

EAN 2025

Type

News article

26 June 2025 13:16

Encouraging results for adaptive DBS for Parkinson’s disease

Presented By

Dr Martijn Beudel , Amsterdam University Medical Center, The Netherlands

Conference

EAN 2025

Type

News article

26 June 2025 13:10

CAR T cell therapy shows promise in severe autoimmune neuropathies

Presented By

Prof. Jeremias Motte , Ruhr-Universität Bochum, Germany

Conference

EAN 2025

Type

News article

26 June 2025 13:02

GLP-1R agonists reduce migraine burden in obese patients

Presented By

Dr Simone Braca, University of Naples, Italy

Conference

EAN 2025

Type

News article

25 June 2025 10:51

Is ChatGPT helpful in diagnosing polyneuropathies?

Presented By

Dr Alberto De Lorenzo, University of Milan, Italy

Conference

EAN 2025

Type

News article

25 June 2025 10:49

Lecanemab in AD: not a paradigm shift, but a small step forward

Presented By

Dr Matilde Bruno, University of Rome Tor Vergata, Italy

Conference

EAN 2025

Type

News article

25 June 2025 10:49

Dementia doubles mortality risk 1 year after hip fracture

Presented By

Prof. Dorota Religa, Karolinska Institutet, Sweden

Conference

EAN 2025

Type

News article

25 June 2025 10:48

Real-world data confirms effectiveness and safety of ofatumumab in MS

Presented By

Dr Gina Ferrazzano, University of Rome Tor Vergata, Italy

Conference

EAN 2025

Type

News article

25 June 2025 10:46

Virus-specific T cells show promise in treating PML

Presented By

Dr Lea Grote-Levi, Hannover Medical School, Germany

Conference

EAN 2025

Type

News article

24 June 2025 12:29

Comparable effectiveness and persistence of ocrelizumab, natalizumab

Presented By

Dr Elena Barbuti, Sapienza University of Rome, Italy

Conference

EAN 2025

Type

News article

24 June 2025 12:28

Why a good result of migraine treatment may not be good enough

Presented By

Dr Edoardo Caronna, Vall d’Hebron University Hospital, Spain

Conference

EAN 2025

Type

News article

24 June 2025 12:27

Long-term benefits of cipa/mig in late-onset Pompe disease

Presented By

Prof. Antonio Toscano, University of Messina, Italy

Trial

Phase 3, PROPEL

Conference

EAN 2025

Type

News article

24 June 2025 12:26

Earlier add-on treatment in myasthenia gravis improves outcomes

Presented By

Dr Menekse Öztürk, Heinrich Heine University Düsseldorf, Germany

Conference

EAN 2025

Type

News article

24 June 2025 12:23

Medical Conferences

EAN 2025

Featured articles

Lecanemab in AD: not a paradigm shift, but a small step forward

Why a good result of migraine treatment may not be good enough

CONTENTS

Online First

Similar efficacy of anti-CGRP mAbs in short- and long-term migraine prevention

Occipital nerve stimulation is no more effective than placebo in cluster headache

Rituximab does not halt progression in non-active secondary progressive MS

Encouraging results for adaptive DBS for Parkinson’s disease

CAR T cell therapy shows promise in severe autoimmune neuropathies

GLP-1R agonists reduce migraine burden in obese patients

Is ChatGPT helpful in diagnosing polyneuropathies?

Lecanemab in AD: not a paradigm shift, but a small step forward

Dementia doubles mortality risk 1 year after hip fracture

Real-world data confirms effectiveness and safety of ofatumumab in MS

Virus-specific T cells show promise in treating PML

Comparable effectiveness and persistence of ocrelizumab, natalizumab

Why a good result of migraine treatment may not be good enough

Long-term benefits of cipa/mig in late-onset Pompe disease

Earlier add-on treatment in myasthenia gravis improves outcomes